Price Action Weighed on Coinbase Global’s (COIN) Performance in Q4

分组1 - Patient Opportunity Equity Strategy achieved a return of 5.99% net of fees in Q4 2025, outperforming the S&P 500 Index which returned 2.65% [1] - The market experienced a strong year with a total return of 17.9%, marking the seventh-best three-year period in market history [1] - The strategy outperformed the S&P 500 for the third consecutive year with a total return of 26.1% in 2025 [1] 分组2 - Coinbase Global, Inc. (NASDAQ:COIN) is a platform for trading and managing crypto assets, with a market capitalization of $56.34 billion [2] - Coinbase's stock closed at $208.93 per share on March 04, 2026, with a one-month return of 42.99% but a 52-week loss of 2.45% [2] - Coinbase was a top detractor in Q4 2025 as crypto-related equities declined alongside digital asset prices, but the company is evolving into a broader financial exchange [3] - The expansion of Coinbase into products like its own layer-2 blockchain, equity trading, and stable coins is expected to enhance engagement and diversify revenues [3]